Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Fredrikstad – page 6

89 clinical trials in Fredrikstad, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Fredrikstad at a glance
89
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

89 trials in Fredrikstad

Open in trial search

Ischaemic stroke+2

Not recruiting

Study on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Mezagitamab
  • Sponsor:Takeda Development Center Americas Inc.

A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Eltrombopag
  • Sponsor:Novartis Pharma AG

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Giant cell arteritis

Not recruiting

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

InvestigationalNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Embolism venous

Not recruiting

Study Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Embolism venous+1

Not recruiting

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Cortisone
  • Sponsor:Helse Bergen HF

Study of BT8009 Alone or with Pembrolizumab for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Bicycletx Limited

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Fredrikstad

What the registry says about research in the country

01 Oncology Research

Innovative studies focusing on precision cancer medicine for rare and hard-to-treat cancers, including groundbreaking research in metastatic prostate cancer and melanoma treatment approaches.

  • Advanced Cancer Therapies
  • Targeted Drug Development
  • Biomarker-Driven Treatment

Research emphasizes personalized treatment strategies and novel drug applications.

02 Hematology Studies

Comprehensive research on Immune Thrombocytopenia (ITP) and related blood disorders, evaluating new therapeutic approaches and drug efficacy.

  • Blood Disorder Treatments
  • Thrombosis Management
  • Innovative Drug Therapies

Focus on developing effective treatments for various blood-related conditions.

03 Neurological & Mental Health

Studies examining treatment outcomes in schizophrenia patients, with particular attention to cognitive impairment and long-term safety assessments.

  • Cognitive Function
  • Mental Health Therapeutics
  • Safety Evaluations

Emphasis on improving patient outcomes through targeted interventions.

04 Musculoskeletal Conditions

Research investigating treatments for rheumatoid arthritis and chronic low back pain, including innovative therapeutic monitoring approaches.

  • Pain Management
  • Inflammatory Conditions
  • Drug Monitoring Studies

Focus on improving quality of life through effective disease management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.